In breast cancer, loss of Akkermansia muciniphila-derived butyrate, a histone deacetylase (HDAC) inhibitor that suppresses Wnt/β-catenin signaling via LRP5 destabilization, promotes tumor stemness and accelerates tumor progression 25. Here, LRP5 is linked to neoplasm.